Xueguo Liu

Dr. Xueguo Liu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Closed access
PDF file
LMLiting Mao
Liting Mao
HCHuan Chen
Huan Chen
MLMingzhu Liang
Mingzhu Liang
KLKunwei Li
Kunwei Li
JGJiebing Gao
Jiebing Gao
XLXueguo Liu
Xueguo Liu
Background: It is a permanent challenge to differentiate small solid lung nodules. Massive data, extracted from medical image through radiomics analysis, may help early diagnosis of lung cancer. The aim of this study was to assess the usefulness of a quantitative radiomic model developed from baseline low-dose computed tomography (LDCT) screening for the purpose of predicting malignancy in small solid pulmonary nodules (SSPNs). Methods: This retrospective study included malignant and benign SSPNs (6 to 15 mm) detected in baseline low-dose CT screening. The malignancy was confirmed pathologically, and benignity was confirmed by long term follow-up or pathological diagnosis. The non-contrast CT images were reconstructed with a lung kernel of a slice thickness of 1 mm and were processed to extract 385 quantitative radiomic features using Analysis-Kinetic software. A predictive model was established with the training set of 156 benign and 40 malignant nodules, and was tested with the validation set of 77 benign and 21 malignant nodules through the analysis of R square. The performance of the radiomic model in predicting malignancy was compared with that of the ACR Lung Imaging Reporting and Data System (ACR lung-RADS). Results: In 294 cases of SSPNs, 61 lung cancers and 24 benign nodules were confirmed pathologically and the remaining 209 nodules were stable with long-term follow-up (4.1±0.9 years). Eleven non-redundant features, including 8 high-order texture features, were extracted from the training data set. The sensitivity and specificity of the prediction model in malignancy differentiation were 81.0% and 92.2% respectively. The accuracy was superior to ACR-lung RADS (89.8% vs. 76.5%). Conclusions: A radiomic model based on baseline low-dose CT screening for lung cancer can improve the accuracy in predicting malignancy of SSPNs.

27 June 2020 in European Radiology
Verified
Journal Article
Open access
PDF file
BFBao Feng
Bao Feng
XCXiangMeng Chen
XiangMeng Chen
YCYeHang Chen
YeHang Chen
SLSenLiang Lu
SenLiang Lu
KLKunFeng Liu
KunFeng Liu
XLXueguo Liu
Xueguo Liu
Objectives To evaluate the differential diagnostic performance of a computed tomography (CT)-based deep learning nomogram (DLN) in identifying tuberculous granuloma (TBG) and lung adenocarcinoma (LAC) presenting as solitary solid pulmonary nodules (SSPNs). Methods Routine CT images of 550 patients with SSPNs were retrospectively obtained from two centers. A convolutional neural network was used to extract deep learning features from all lesions. The training set consisted of data for 218 patients. The least absolute shrinkage and selection operator logistic regression was used to create a deep learning signature (DLS). Clinical factors and CT-based subjective findings were combined in a clinical model. An individualized DLN incorporating DLS, clinical factors, and CT-based subjective findings was constructed to validate the diagnostic ability. The performance of the DLN was assessed by discrimination and calibration using internal (n = 140) and external validation cohorts (n = 192). Results DLS, gender, age, and lobulated shape were found to be independent predictors and were used to build the DLN. The combination showed better diagnostic accuracy than any single model evaluated using the net reclassification improvement method (p < 0.05). The areas under the curve in the training, internal validation, and external validation cohorts were 0.889 (95% confidence interval [CI], 0.839–0.927), 0.879 (95% CI, 0.813–0.928), and 0.809 (95% CI, 0.746–0.862), respectively. Decision curve analysis and stratification analysis showed that the DLN has potential generalization ability. Conclusions The CT-based DLN can preoperatively distinguish between LAC and TBG in patients presenting with SSPNs. Key Points • The deep learning nomogram was developed to preoperatively differentiate TBG from LAC in patients with SSPNs. • The performance of the deep learning feature was superior to that of the radiomics feature. • The deep learning nomogram achieved superior performance compared to the deep learning signature, the radiomics signature, or the clinical model alone.

28 August 2021 in European Radiology
Verified
Journal Article
Closed access
PDF file
KLKunfeng Liu
Kunfeng Liu
KLKunwei Li
Kunwei Li
TWTingfan Wu
Tingfan Wu
MLMingzhu Liang
Mingzhu Liang
YZYinghua Zhong
Yinghua Zhong
XLXueguo Liu
Xueguo Liu

8 July 2020 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
XCXiangmeng Chen
Xiangmeng Chen
BFBao Feng
Bao Feng
YCYehang Chen
Yehang Chen
KLKunfeng Liu
Kunfeng Liu
KLKunwei Li
Kunwei Li
XLXueguo Liu
Xueguo Liu
Purpose: To develop a radiomics nomogram based on computed tomography (CT) images that can help differentiate lung adenocarcinomas and granulomatous lesions appearing as sub-centimeter solid nodules (SCSNs). Materials and methods: The records of 214 consecutive patients with SCSNs that were surgically resected and histologically confirmed as lung adenocarcinomas (n = 112) and granulomatous lesions (n = 102) from 2 medical institutions between October 2011 and June 2019 were retrospectively analyzed. Patients from center 1 ware enrolled as training cohort (n = 150) and patients from center 2 were included as external validation cohort (n = 64), respectively. Radiomics features were extracted from non-contrast chest CT images preoperatively. The least absolute shrinkage and selection operator (LASSO) regression model was used for radiomics feature extraction and radiomics signature construction. Clinical characteristics, subjective CT findings, and radiomics signature were used to develop a predictive radiomics nomogram. The performance was examined by assessment of the area under the receiver operating characteristic curve (AUC). Results: Lung adenocarcinoma was significantly associated with an irregular margin and lobulated shape in the training set (p = 0.001, < 0.001) and external validation set (p = 0.016, = 0.018), respectively. The radiomics signature consisting of 22 features was significantly associated with lung adenocarcinomas of SCSNs (p < 0.001). The radiomics nomogram incorporated the radiomics signature, gender and lobulated shape. The AUCs of combined model in the training and external validation dataset were 0.885 (95% confidence interval [CI]: 0.823–0.931), 0.808 (95% CI: 0.690–0.896), respectively. Decision curve analysis (DCA) demonstrated that the radiomics nomogram was clinically useful. Conclusion: A radiomics signature based on non-enhanced CT has the potential to differentiate between lung adenocarcinomas and granulomatous lesions. The radiomics nomogram incorporating the radiomics signature and subjective findings may facilitate the individualized, preoperative treatment in patients with SCSNs.

1 August 2011 in Lung Cancer
Verified
Journal Article
Closed access
XLXueguo Liu
Xueguo Liu
MLMingzhu Liang
Mingzhu Liang
YWYong Wang
Yong Wang
KCKai Chen
Kai Chen
XCXiangmeng Chen
Xiangmeng Chen
XYXianping Yi
Xianping Yi

1 August 2021 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
KLKunwei Li
Kunwei Li
KLKunfeng Liu
Kunfeng Liu
YZYinghua Zhong
Yinghua Zhong
MLMingzhu Liang
Mingzhu Liang
PQPeixin Qin
Peixin Qin
XLXueguo Liu
Xueguo Liu
Background: Artificial intelligence (AI) products have been widely used for the clinical detection of primary lung tumors. However, their performance and accuracy in risk prediction for metastases or benign lesions remain underexplored. This study evaluated the accuracy of an AI-driven commercial computer-aided detection (CAD) product (InferRead CT Lung Research, ICLR) in malignancy risk prediction using a real-world database. Methods: This retrospective study assessed 486 consecutive resected lung lesions, including 320 adenocarcinomas, 40 other malignancies, 55 metastases, and 71 benign lesions, from September 2015 to November 2018. The malignancy risk probability of each lesion was obtained using the ICLR software based on a 3D convolutional neural network (CNN) with DenseNet architecture as a backbone (without clinical data). Two resident doctors independently graded each lesion using patient clinical history. One doctor (R1) has 3 years of chest radiology experience, and the other doctor (R2) has 3 years of general radiology experience. Cochran’s Q test was used to assess the performances of the AI compared to the radiologists. Results: The accuracy of malignancy-risk prediction using the ICLR for adenocarcinomas, other malignancies, metastases, and benign lesions was 93.4% (299/320), 95.0% (38/40), 50.9% (28/55), and 40.8% (29/71), respectively. The accuracy was significantly higher in adenocarcinomas and other malignancies compared to metastases and benign lesions (all P<0.05). The overall accuracy of risk prediction for R1 was 93.6% (455/486) and 87.4% for R2 (425/486), both of which were higher than the 81.1% accuracy obtained with the ICLR (394/486) (R1 vs. ICLR: P<0.001; R2 vs. ICLR: P=0.001), especially in assessing the risk of metastases (P<0.05). R1 performed better than R2 at risk prediction (P=0.001). Conclusions: The accuracy of the ICLR for risk prediction is very high for primary lung cancers but poor for metastases and benign lesions.